✦ LIBER ✦

Tianeptine and its main metabolite. Disposition in chronic renal failure and haemodialysis

✍ Scribed by C. Salvadori; H. Merdjan; R. Brouard; A. Baumelou; G. Nicot; D. Friès

Book ID: 115273773
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 447 KB
Volume: 4
Category: Article
ISSN: 0767-3981
DOI: 10.1111/j.1472-8206.1990.tb00046.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paracetamol disposition and metabolite k

Paracetamol disposition and metabolite kinetics in patients with chronic renal failure

✍ L. F. Prescott; G. C. Speirs; J. A. J. H. Critchley; R. M. Temple; R. J. Winney 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 943 KB

Delayed disposition of adriamycin and it

Delayed disposition of adriamycin and its active metabolite in haemodialysis patients

✍ M. Goto; H. Yoshida; A. Honda; T. Kumazawa; T. Ohbayashi; J. Inagaki; N. Yamanak 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 181 KB

Delayed elimination of triamterene and i

Delayed elimination of triamterene and its active metabolite in chronic renal failure

✍ H. Knauf; W. Möhrke; E. Mutschler 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 401 KB

Effect of Severe Renal Failure and Haemo

Effect of Severe Renal Failure and Haemodialysis on the Pharmacokinetics of Levosimendan and Its Metabolites

✍ Dr Jaakko Puttonen, Sampo Kantete, Matti Kivikko, Sari Häkkinen, Veli-Pekka Harj 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 172 KB

Tricyclic antidepressant and metabolite

Tricyclic antidepressant and metabolite levels in chronic renal failure

✍ Lieberman, Jeffrey A; Cooper, Thomas B; Suckow, Raymond F; Steinberg, Herbert; B 📂 Article 📅 1985 🏛 Nature Publishing Group 🌐 English ⚖ 585 KB

Pharmacokinetics of torasemide and its m

Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure

✍ H. Spahn; H. Knauf; E. Mutschler 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 344 KB

The pharmacokinetics of 20 mg torasemide i.v. has been studied in 7 healthy controls and 9 patients with varying degrees of renal impairment. Torasemide had a t1/2 of about 4h which was independent of kidney function, as the nonrenal clearance of torasemide was 3-times greater than its renal clearan